GSK : Analysis & Opinions

  1. Chinese Opportunities For A Changing Child Policy

    May 21, 2015
    China's one-child policy is changing, and investors are looking for ways to cash in. The reform might not have the effects ...
  2. 3 Top Pharma Stocks that Pay Regular Dividends

    May 1, 2015
    The low down on three big name, dividend-paying pharma stocks.
  3. How the UK Makes Money

    April 29, 2015
    The United Kingdom has one of the strongest economies in the world thanks to the strength of its services, manufacturing ...
  4. How China Makes Money

    April 28, 2015
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  5. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  6. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  7. Hedge Your European Exposure With This Savvy ETF

    February 9, 2015
    The European Central Bank's (ECB) recent announcement of a huge bond-buying program has made investors understandably giddy. ...
  8. How To Profit From These 3 Overvalued Sectors

    January 22, 2015
    Flea markets crack me up. Most of the vendors seem like they cleaned the junk from their garage and assigned an arbitrary, ...
  9. The Best- and Worst-Performing Healthcare Stocks

    November 3, 2014
    Here are the best- and worst-performing stocks YTD in the healthcare sector with at least $2B in market cap and over 1 million ...
  10. Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  11. Learn How To Invest Defensively From This Hedge Fund Pro

    May 21, 2014
    With the Dow Jones Industrial Average and the S&P 500 hovering near all-time highs and plenty of investors shifting to a ...
  12. Sectors and Stocks to Watch This Week

    March 3, 2014
    Very strong coming into this week, these are sectors and stocks to keep an eye on.
  13. European Stocks Are Ripe For The Picking

    February 26, 2014
    Things continue to get better for Europe. After going through some pretty nasty side-effects in the aftermath of the Great ...
  14. The United Kingdom Is Ripe For Stock Pickers

    December 6, 2013
    With the situation in Europe finally moving ahead, investors may want to focus on the United Kingdom. Stocks within the nation ...
  15. A Strong Prognosis For Healthcare Stocks

    November 19, 2013
    Despite the healthcare sectors recent torrid run, there’s still plenty to like about stocks in the industry. Aside from tailwinds ...
  16. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  17. Vertex Building A Fortress In Cystic Fibrosis

    August 28, 2013
    Vertex is in the early days of what could be a $10B franchise in cystic fibrosis treatment.
  18. Prestige Brands Gets Upgraded: Should You Be Buying?

    July 11, 2013
    At least two investment firms upgraded Prestige Brands' (NYSE:PBH) stock July 9 on news it had acquired a small Australian ...
  19. Big Pharma Faces 'Pay For Delay' Lawsuits

    June 21, 2013
    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of ...
  20. AstraZeneca Pays Up To Patch Up Another Key Area

    June 10, 2013
    In buying Pearl, AstraZeneca is taking some of the risk out of its valuable COPD franchise.
  21. Elan Continues To Make Baffling Strategic Decision

    May 21, 2013
    Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
  22. Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges

    May 9, 2013
    More questions about the real efficacy of fish oil is bad news for Amarin.
  23. Gains of 27%, 56%, and even 183%... What's Next?

    January 2, 2013
    It's every investor's dream. And this one came true... For lucky shareholders in this formerly tiny maker of automated medicine ...
  24. A Triple Play Of Biotech Disappointments Last Week

    December 28, 2012
    Investors got a triple-dose of bad biotech news this week.
  25. BASF's Deal For Pronova Shows The Importance Of Good Nutrition

    November 23, 2012
    BASF ties up another high-grade fish oil company in Pronovna, adding to the recent rise in popularity for the fish oil space.
  26. UK's Global Footprint Stocks

    June 27, 2012
    Looking across the pond at the UK, one can't help but be attracted to some of the opportunities.
  27. Eli Lilly Paying Investors To Wait

    May 3, 2012
    The pharmaceutical giant reported decent first quarter results late in April 2012. However, It will likely be some time before ...
  28. Truly a World-Class Fund

    April 26, 2012
    There’s no one place for growth any longer, so it pays to diversify across world markets and few funds do it better than ...
  29. 2011 In Review - Pharmaceuticals

    December 29, 2011
    2011 was a surprisingly healthy year for drug stocks.
  30. Is Third Time The Charm For Gilead?

    November 22, 2011
    Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.
  31. The 3 Highest Yielding Pharma Stocks

    September 30, 2011
    Learn more about three large pharmaceutical companies with the highest current yields.
  32. Despite Inflation Woes India Outshines In Asia

    September 23, 2011
    Despite its inflationary pressures, India's strength and investment potential continues to grow.
  33. Betting On Healthcare's Growth Engine

    August 17, 2011
    In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
  34. Top Dividend Stocks Owned By The Pros

    August 2, 2011
    Selecting from the top dividend stocks owned by professional investors may give your portfolio a boost.
  35. Buffett's Profitable Positions

    July 13, 2011
    See 5 stocks that have been profitable for Warren Buffett.
  36. 10 Drug Stocks for Safety and Yields

    June 26, 2011
    Big pharma is an attractive destination for traders and investors looking for safety, yields, and solid value in the current ...
  37. Dividends To Avoid

    May 4, 2011
    A company that offers dividends isn't always a safe long-term bet. Find out which dividend-issuing companies you should avoid.
  38. Glaxo And Human Genome Find Rare FDA Success

    March 10, 2011
    With an increasingly scarce FDA approval in hand, HGSI and GSK look to build a blockbuster drug.
  39. U.K. A Value Bet Amid Euro Debt Crisis

    January 20, 2011
    The ongoing financial crisis in the European Union has made the United Kingdom a promising prospect for value investors. ...
  40. InterMune - The Black Knight Of Biotech?

    December 21, 2010
    Possible European approval could save the day for this risky biotech.
  41. Human Genome Takes A Big Step Forward

    November 17, 2010
    HGSI's prospects get a big boost from a panel approval.
  42. Expected Increase In Research And Development

    November 8, 2010
    Research & Development (R&D) is the key to success in the pharmaceutical industry, but just how much of an impact ...
  43. Cancer Vaccines Continue To Show Promise

    July 7, 2010
    Dendreon has put cancer vaccines back in the spotlight, but can they live up to their hype?
  44. Can Investors Fatten Up On Weight Loss?

    June 22, 2010
    Obesity is described as a multi-billion dollar crisis in North America, but how can investors profit from the solutions?
  45. The Future of Stem Cells

    June 15, 2010
    Stem cells get a lot of attention, but maybe not in the one area where they could prove most effective.
  46. FDA Makes InterMune Sick

    May 10, 2010
    Should investors hang on despite a devastating FDA decision?
  47. Dividends With Earnings Growth

    April 23, 2010
    These healthcare and pharma companies have a solid dividend and increasing earnings over the last five years.
  48. Fighting The Unstable European Union

    March 3, 2010
    Protection is the name of the game, and these options can help shield you from a volatile European Union.
  49. Four High-Flying Pharmaceutical Companies

    October 28, 2009
    A look at some of the best-performing stocks year to date - up anywhere from 400% to 2000%.
  50. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others.
  51. Swine Flu Vaccine: Quantity Over Quality

    July 20, 2009
    The swine flu vaccine race appears to have multiple winners.
  52. Dividend Darlings Or Dividend Disappointments?

    March 26, 2009
    Even with declining sales, Whirlpool has the stock prices and dividend yields that make it a company of interest.
  53. Will Emergent BioSolutions Finally Retreat?

    January 12, 2009
    Having lost positive earnings and revenue momentum, EBS is looking less healthy in 2009.
  54. Ride The Ups And Downs Of Drug Approval

    October 16, 2008
    The FDA's complex drug approval process provides plenty of volatility for short-term traders to feast upon.
  55. Abbott Labs Finally Turns Potential Into Profit

    April 17, 2008
    Solid numbers for the last two quarters could change Abbott Labs's reputation as an overvalued stock.
  56. You Gotta Know When To Bail

    February 22, 2007
    When your stock's prospects take a turn for the worse, bailing out can be the best possible option.
  57. Winners and Losers - September 4th - 8th (SYX, BNP, EFX, ADLR, ...

    September 8, 2006
    A look at the winners and losers for the week of September 4th.
  58. Pfizer, Pass the Rolaids

    June 12, 2006
    $15 billion for its consumer products unit won’t cure Pfizer’s ailing stock.
  59. A Look at Economic Moats - Part 2

    November 23, 2005
    In this piece we'll explore different types of economic moats.
Trading Center